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ABSTRACT
Background: Cornea injury of sulfur mustard (SM) is considered as the most devastating injuries to
the eye. This study aimed to evaluate the single and combined effects of N-acetyl cysteine (NAC) and
doxycycline on the inflammatory pathway and cornea neovascularization (CNV) in the rat model of
SM-injured cornea.
Materials and methods: The right cornea of male Sprague–Dawley rats was subjected to 2-chlor-
oethyl-ethyl sulfide (CEES). Rats were topically treated with a single and combined of 0.5% NAC and
12.5lg/ml doxycycline and examined at 3rd, 15th, and 21st days. The activity of three antioxidant
enzymes was analyzed in the cornea of different groups. Real-time PCR was performed to measure
gene expression of inflammatory factors (tnf-a, rel-a & cxcl-1) and angiogenesis factors (vegf-a,
mmp2,9) in the cornea lysates. The histological and opacity assessments were also carried out.
Results: The activity of antioxidant enzymes significantly declined 3days after the CEES damage. NAC
eye drop recovered the enzyme activity on the 21st day of treatment (p-value < .05). The expression
of tnf-a and rel-a genes significantly increased after CEES cornea exposure, while NAC declined their
expression on the 7th and 21st days. The CNV score and angiogenesis factor expression were
decreased in the long term by single and combined treatments (p-value < .05), but the infiltration of
inflammatory cells was not completely amended.
Conclusion: NAC and doxycycline eye drop could improve the CNV complication. Also, NAC was an
effective treatment against the inflammatory pathway involved in CEES-injured cornea.
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Vesicating chemical warfare agents cause the body severe
damages, particularly in respiratory, skin, and ocular systems.
Sulfur mustard (SM; bis [2-chloroethyl] sulfide) has been
widely used as the vesicating agent, which can induce ocular
injury [1]. The symptoms such as photophobia, corneal ulcer-
ation, and lacrimation are clinically manifested the acute ocu-
lar injury following 2–6 h exposure. In the delayed phase, the
ocular injury develops conjunctival scarring, corneal neovas-
cularization (CNV), inflammation, and epithelial cornea
defects that can result in progressive visual impairment [2,3].
SM can penetrate the corneal epithelium and damage cell
structure by producing high levels of reactive oxygen species
(ROS), reactive nitrogen species (RNS) [1].
The pro-inflammatory cytokines are the first mediators
released after oxidative stress at the cornea to stimulate
immune system cells [3,4]. The use of topical corticosteroids
and nonsteroidal anti-inflammatory drugs (NSAIDs) cannot
efficiently recover the CNV and inflammation caused by SM-
induced ocular injury. Understanding the pathological mecha-
nisms of SM-induced ocular injury may lead to developing
effective therapeutic strategies [4,5]. There is a global effort to
find out appropriate therapeutic strategies for SM-induced ocu-
lar injury, however, after a century, investigations have not able
to represent an approved U.S. Food and Drug Administration
(FDA) countermeasures against SM-injured cornea [6].
N-Acetyl cysteine (NAC), a precursor of the amino acid
cysteine with thiol agent, scavenges ROS through increasing
the level of mitochondrial and cytosolic glutathione [7].
Several studies have shown that NAC has a long-term effect
in preventing damage to the protein and DNA of cells
exposed to the active oxidants compounds [8,9]. NAC also
reduces the expression of the NF-jB transcription factor by
reducing intracellular thioredoxin [10]. Investigations have
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reported the anti-inflammatory properties of tetracycline
family antibiotics in human corneal epithelial cells [11,12].
Doxycycline is a semisynthetic long-acting tetracycline with
anti-inflammatory effects that are attributed to the inhibition
of p38 MAPK signaling [13]. Besides, doxycycline can reduce
the migration of immune cells to the cornea of the alkali-
burned mice model [14].
2-Chloroethyl-ethyl sulfide (CEES) is a structural analog of
SM modifying biomolecules within the cell and causes ocular
injury similar to SM [6]. In this study, we evaluated the clinical
and pathophysiological effects of single and combined topical
treatment of NAC and doxycycline against CEES-injured cornea
in rat models. During a 21-day post-exposure, molecular and
intensity of oxidative stress indicating the state of inflamma-
tory and angiogenesis factors were analyzed at 3rd, 7th, and
21st days. Also, histological data were examined to under-
stand the possible healing effects of treatments on the injury.
Material and method
Animal models and experimental design
A total of 90 healthy male Sprague–Dawley (SD) rats, weigh-
ing from 180–220 g, were used in this study. The rats were
kept at suitable conditions with 40–60% humidity, 24 ± 2 C
temperature, 12 h of light, and 12 h of darkness. The treat-
ment procedure was applied in accordance with the Animal
use guidelines 2016 published by the Association for
Research in Vision and Ophthalmology (ARVO) [15]. This
experiment was approved by the Regional Research Ethics
Committee of Bagiatollah Medical Sciences University
(IR.BMSU.REC.1398.380). All rats were randomly divided into
five groups that each group includes 18 rats: Group 1
(Healthy group): no CEES injury and right eyes were treated
by normal saline drop as the vehicle-treated group; Group 2
(CEES group): right eyes were exposed to CEES at the 0 day;
Group 3 (NACþCEES group): right eyes were treated with
NAC drop following CEES corneal exposure; Group 4
(DoxþCEES group): right eyes were treated with doxycycline
drop following CEES corneal exposure; Group5:
(DoxþNACþCEES group): right eyes were treated with
doxycycline and NAC drop following CEES corneal exposure.
The CEES corneal injury occurred on day 0. Six rats from
each group were euthanized 3, 7, and 21 days after injury
and scarified for the next experiments.
In vivo animal model of corneal SM injury
Before beginning the study, all rats received 0.3% tobramycin
eye drops to prevent corneal infection [16]. At the 0 day, rats
belonging to the groups 2–5 were anesthetized by 35mg/kg
body weight, ketamine hydrochloride 10% and xylazine 2%
combination (Alfasan Company, Woerden, The Netherlands)
to painless the corneal analgesia. The right eyes of rats were
maintained open, and corneal analgesia was creating by
dropping 10 ll neat CEES (24ll of 98% CEES liquid was ini-
tially dispersed into 76ml of 100% ethanol to produce 2M
concentration of CEES, and then was dissolved in normal
saline to produce 3 l mol/ml CEES) (Sigma-Aldrich, St. Louis,
MO, CAS no. 693-07-2) according to a similar study [17]. The
CEES was placed at the center of the cornea for 45 s.
Subsequently, the cornea was rapidly washed with 200 ll
sterile saline solution for three times. In addition to clinical
assessment. The occurrence of the corneal injury was
checked with a slit lamp 4h after CEES exposure.
The right eyes of the NACþCEES group were treated
twice daily with 1 drop of 0.5% NAC (Exir Pharmaceutical
Company, Tehran, Iran) dissolved in normal saline solution at
a pH of 7.4 [18]. The right eyes of the DoxþCEES group
were treated with 1 drop of purified liquid doxycycline
(12.5 lg/ml) (Kimiadoxy 50R, Iran) applied two times per day
[19]. The right eyes of the rats of group 5
(DoxþNACþCEES) were treated with 1 drop of doxycycline
(12.5 lg/ml) two times per day, and 1 drop of 0.5% NAC 2
times per day separately to prevent the possible interaction
between NAC and Dox. Right eyes were unexposed and
were used as internal controls.
Rats were anesthetized by 35mg/kg body weight, keta-
mine hydrochloride, and xylazine combination, and then,
were scarified. The cornea and the aqueous humor were rap-
idly separated for the next experiments. From each group,
three tissues were kept at 10% buffered formalin for histo-
logical examination, and three tissues were used for molecu-
lar and biochemical analysis, as described below.
Corneal opacity and neovascularization scoring
The degree of opacification was assessed during 21 days
after CEES-exposed cornea according to the Oxford system
[20]. Clinical assessments were also performed at 1, 3, 7, and
21 days to measure the haze degree and scored between 0
and 4 numerical scales. 0: clear cornea; 1: slight stromal opa-
city with pupil margin; 2: moderate stromal opacity with only
pupil margin visible; 3: intense corneal opacity with difficultly
anterior visible; and 4: maximal corneal opacity without the
ability to view the anterior chamber.
Neovascularization initiated from dilated limbal was based
on the extent of centripetal invasion of the vessels in the
cornea regions. On the 3rd, 7th, and 21st days, the slit lamp
biomicroscope was scored 0–3 for each corneal based on a
similar study [21] (0: no neovessels; 1: neovessels at the cor-
neal limbus; 2: neovessels spanning the corneal limbus and
approaching the corneal center, and 3: neovessels spanning
the corneal center). Vessel branches, which were not pene-
trated into the corneal stroma, had not been counted for
neovascularization.
Histological analyses
The anterior part of the eye, including the cornea and aque-
ous humor (anterior chamber), was fixed in 10% buffered for-
malin for 24 h. Subsequently, samples were embedded in
paraffin and cut into 5-lm thick. After deparaffinization, tis-
sues were stained with hematoxylin and eosin (H&E) for
histopathological examination, the thickness of the cornea,
the numbers of polymorph nuclear cells infiltrated into the
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cornea, and the intensity of neovascularization were meas-
ured by the digital image analyzer.
Real-time PCR
Three corneal tissues from each group were divided into two
equal parts. One part was homogenized in a 1ml RNX-Plus
reagent (Cat. no. EX6101; SinaClon BioScience, Tehran, Iran)
for extract RNA, and another part was used for biochemical
experiments. The purification and quantity of total RNA were
measured using a Thermo ScientificTM NanoDrop 2000
(Thermo Fisher Scientific Co., Waltham, MA) at 260/280–260/
230 ratios, and then cDNA was synthesized with Revert Aid
first-strand cDNA synthesis kit (YTA, Tehran, Iran) according
to the manufacturer’s instructions.
The real-time PCR was applied to indicate quantification
of mRNA on a Rotor-Gene RG-300 (Corbett Research, Sydney,
Australia) and SYBR Green Real-time PCR Master Mix Kit
(TAKARA, Tokyo, Japan, catalog no. RR820Q). In detail, ther-
mal cycling that was exploited in the process started with
denaturation step at 95 C for 5min, and followed by 38
cycles of 95 C for 15 s, 61 C for 20 s, and 72 C for 25 s.
Relative expression levels of tnf-a, nf-jB, cxcl-1, vegf and
mmp2, 9 genes were calculated using the (2DDCt) method;
and normalized versus expression of b-actin gene. The pri-
mer sequences are documented in Supplementary data files.
Biochemical examination
Three corneal tissues stored at 80 C from each group were
placed in the cold PBS (100mM, pH 7.4), and then homogen-
ized at 4000–6000 RPM. After that, supernatant was collected,
and transfer to a clean tube to determine the catalase (CAT),
superoxide dismutase (SOD), and glutathione peroxidase
(GPx) activities by calorimetrically enzymatic assay kits
(ZellBio GmbH, Ulm, Germany). The sensitivity of these kits
were 0.5 U/mg.
Statistical analysis
All data were normal and presented as mean± SD. The two-
way ANOVA was used to perform the statistical analysis of
the results. The data of CEES group (group 2) were analyzed
in comparison to other groups at 3, 7, and 21 days separ-
ately. Spearman correlation analysis was also used to esti-
mate the correlations between gene expression. GraphPad
Prism software version 6 (GraphPad Software, San Diego, CA)
used for data analyses. The p-value was set < .05 as statistic-
ally significant.
Results
NAC treatment altered the antioxidant defense system
of the cornea under CEES-induced damage
We first evaluated innate antioxidant defense consistent with
the single and combined topical treatment of NAC and Dox
in CEES-damage cornea. In comparison with CEES group
(group 2), antioxidant enzymes activity of other groups was
separately analyzed at 3, 7, and 21 days. As the CAT, SOD,
and GPx activities were previously shown to be affected in
sulfur mustard exposure [22]. The activity of all these
enzymes significantly declined by three-fold on day 3 after
the CEES damage in the CEES group compared to the
healthy cases (p-value < .05). Furthermore, these enzyme
activities remained low in the entire period of the experi-
ment (Figure 1). It was noticeable that the CAT and SOD
activity levels significantly increased to 6.775 and 77.395U/
mg on the 21st day of NACþCEES treatment (group 4);
Figure 1. Antioxidant activity in the cornea during 3, 7, and 21 days time period after CEES injury. The CAT (A) and SOD activity (B) showed an increase in the
NAC-treated group 21 days following CEES cornea damage (p-value < .05), but changes in the GPx were not statistically significant. Data were expressed as
mean ± SD. Indicators p-value  .05: , p-value  .01: , p-value  .001: compared with the CEES group at 3rd, 7th, and 21st days separately. CAT: catalase;
SOD; superoxide dismutase; GPx: glutathione peroxidase; Nac: N-acetyl cysteine.
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however, the enhancement of GPx activity in this group had
no statistically significant (p-value > .05; Figure 1(C)).
Although, GPx, CAT, and SOD activity of DoxþCEES and
DoxþNACþCEES groups (groups 3 and5) continued a grad-
ual rise at 7th and 21st days following CEES cornea damage,
but were not fully recovered in the period of 21 days (p
value > .05; Figure 1). Therefore, the NAC treatment revealed
changes in antioxidant defense, particularly in the case of
21 day treatment.
NAC suppressed TNF-a-Rel-a pathway in CEES-
injured cornea
We next evaluated the gene expression of the tnf-a in the
CEES-injured cornea (group 2) by real-time PCR in compari-
son to other groups at 3rd, 7th, and 21st days separately. As
it was reported, TNF-a increased in the injured cornea which
was under oxidative stress [23]. Accordingly, we found a sig-
nificant increase of tnf-a gene expression in the cornea of
the CEES group (group 2) compared to the healthy group
(group 1) in all selected time points (p-value < 0.05; Figure
2(A)). Moreover, the mRNA level of TNF-a at 7th and 21st
days of NACþCEES and DoxþNACþCEES groups (groups 4
and 5) decreased considerably (p-value < .05); however, the
comparison of tnf-a gene expression at 3rd days between
these groups did not show any statistically signification
(Figure 2(A)).
As can be observed in Figure 2(B), the mRNA expression
of rel-a also increased in the cornea of rats treated with CEES
(group 2) than the healthy group at 7th and 21st days.
Similar to tnf-a gene expression, the expression of rel-a gene
declined following the 7th and 21st days of NAC and
DoxþNAC topical treatment (p-value < .05; Figure 2(B)).
According to the spearman correlation analysis, the mRNA
levels of tnf-a in the CEES group positively correlated with
that of in Rel-a CEES group (Table 1). Interestingly, this cor-
relation was also seen in groups 4 and 5, which were treated
with NAC and DoxþNAC (r: 0.863 and 0.730 respectively,
Table 1). Therefore, the use of the NAC drop eye could
attenuate the TNF-a-Rel-a pathway via reducing tnf-a and rel-
a gene expression.
NAC and doxycycline could not decrease cxcl-1
mRNA expression
Based on the Cxcl-1 evaluation carried out by RT-PCR, cxcl-1
gene expression increased in the cornea of rats exposed to
CEES (group 2) compared to healthy cases at 3rd days (p-
value < .05; Figure 3(A)). The comparison of cxcl-1 gene
expression between group 2 and treatment groups at 3rd,
7th, and 21st days did not show any statistically significant
data (p-value > .05). There was a slight decrease in the Cxcl-
1 mRNA expression at 7 and 21 days after cornea damage
with CEES in group 2. Surprisingly, a similar Cxcl-1 expression
pattern was also shown in the all treatment groups (Figure
3(A)). Therefore, the treatment of NAC and Dox does not
seem to affect Cxcl-1 gene expression.
NAC and doxycycline down-regulated angiogenesis
factors at 7th and 21st days
To determine the effects of NAC and Dox on the expression
of angiogenesis factors, the mRNA level of VEGF-A, MMP-2,
and MMP-9 was evaluated. The differential expression of
vegf-a gene in Figure 3(B) showed that the mean vegf-a
gene expression in group 2 seemed to be more than healthy
samples. Similar to rel-a gene expression, mRNA level of
VEGF-A reduced in CEES-injured rats treated with NAC and
Figure 2. TNF-a and Rel-a mRNA level was evaluated in the CEES-injured cor-
nea at the 3rd, 7th, and 21st days by real-time PCR. Compared with the CEES
group, TNF-a (A) and Rel-a (B) mRNA level in NACþ CEES and
DoxþNACþ CEES groups significantly decreased after 7 and 21 days (p-value
< .05). Data were expressed as mean ± SD. Indicators p-value  .05: , p-value
 .01: , p-value  .001: compared with the CEES group at the 3rd, 7th,
and 21st days separately. Nac: N-acetylcysteine; Doxy: doxycycline.












tnf-a & rel-a 0.6862 (.0475) 0.3810 (.3599) 0.863 (.0058) 0.7306 (.0467)
rel-a & cxcl-1 0.2594 (.4815) 0.3095 (.4618) 0.3333 (.4279) 0.5988 (.1237)
rel-a & vegf-a 0.7113 (.0381) 0.1071 (.8397) 0.7857 (.0279) 0.4671 (.2478)
rel-a & mmp2 0.8144 (.0186) 0.1429 (.7520) 0.3571 (.3894) 0.6826 (.0701)
rel-a & mmp9 0.4286 (.2482) 0.2619 (.5364) 0.2619 (.5364) 0.4058 (.4333)
The P-value was set as statistically significant.
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DoxþNAC (groups 4 and 5) at 7th and 21st days. In add-
ition, spearman analysis indicated that vegf-a gene expres-
sion was correlated with the rel-a gene expression in the
NAC-treated group (r: 0.785; p-value: .0279; Table 1).
Interestingly, Dox treatment (group 3) after 7th and 21st
days statistically decreased the mRNA expression of VEGF-A
(p-value < .05). The correlation analysis in Table 1 showed
that there was no correlation between VEGF-A and Rel-a
mRNA expression in the Dox treatment group. Thus, the
VEGF-A mRNA level seemed to be under the effect of both
NAC and Dox treatment; however, the mechanism of Dox
effect on VEGF-A expression was not related to changes in
Rel-a expression.
Figure 3(C,D) indicates that both MMP-2 and MMP-9 as the
main functional enzymes in angiogenesis were overexpressed
in the cornea injured with CEES rather than the healthy cases.
In addition to NAC, Dox topical treatment and combined treat-
ment with DoxþNAC could decrease gene expression of
mmp2, 9 at the 21st day (p-value < .05; Figure 3(C,D)).
Notably, there was no correlation between rel-a and mmp-2,
mmp-9 gene expression in the treatment group, indicating
that the reduction of MMP-2, MMP-9 mRNA expression may
not be related to the decline in Rel-a expression (Table 1).
NAC clinically changed the infiltration of inflammatory
cells and CNV
The effects of NAC and Dox treatments at 3rd, 7th, and 21st
days were investigated by performing histological analyses
using hematoxylin and eosin (H&E) staining. In the case of the
CEES damage model at 3 and 7days (during early phase), the
infiltration of the inflammatory cells was detected in the
cornea, stroma, and anterior chambers. The edema of stroma
and interrupted squamous epithelium were also noticeable in
the CEES group (Figure 4). On the 3rd and 7th days, stroma
exhibited a massive degree of apoptosis in corneal kerato-
cytes. By the 21st day (late phase), dramatic neovascularization
(shown by arrow) and collagen synthesis appeared at the cor-
nea; however, edema was disappeared and the rupture epi-
thelialization process occurred (Figure 4). Corneal
neovascularization scoring indicated that there were signifi-
cant increases in CNV scores in the CEES group from the 7th
day to the 21st day after CEES injury (Figure 5). There was no
obvious differentiation between corneas of the CEES group,
but NACþCEES and DoxþNACþCEES groups after 7 days
displayed a remodeling stromal and slightly recov-
ered epithelium.
Also, the number of inflammatory cells between the
Bowman membrane and Descemet’s membrane was lesser
compared to the CEES cases. Post 21 day treatment with
NAC, a thin epithelium layer appeared over the surface of
the cornea (Figure 4). The greatest inhibitory effect on CNV
was detected in the combined treatment of DoxþNAC drop
eye during 21 days post-injury. The neovascularization
derived from limbus had a significant decline rather than the
CEES group. The CNV score in the DoxþNACþCEES group
(group 5) at 7th and 21st days were 1.4 and 0.8, respectively
(Figure 5), but the existence of a low number of macrophage
cell (MQ) was still seen in the 21st day of groups 3 and 5. It
was noticeable that the neovascularization score at the 21st
day after Dox treatment decreased similar to 21st day
DoxþCEES and DoxþNACþCEES groups. In contrast, the
presence of inflammatory cells infiltrated to stroma was sig-
nificant 7 and 21 days following doxycycline treatment
Figure 3. Cxcl-1, VEGF-A, and MMP2, 9 mRNA level was evaluated at the 3rd, 7th, and 21st days in the cornea of rats exposed to CEES. (A) The cxcl-1 gene expres-
sion did not show any significant reduction in the treatment groups (p-value > .05). (B) VEGF-A mRNA level seemed to be under the effect of both NAC and
Dox treatment. (C and D) The gene expression of mmp2, 9 significantly declined after 21 days of DoxþNAC treatment. Data were expressed as mean ± SD.
Indicators p-value  .05: , p-value  .01: , p-value  .001: compared with the CEES group at the 3rd, 7th, and 21st days separately. Nac: N-acetyl cysteine;
Doxy: doxycycline.
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(Figure 4). Thus, Dox eye drop may provide a therapeutic
agent for inflammatory and angiogenic factors.
The corneal opacity score was lower in both DoxþCEES
and DoxþNACþCEES groups than in the CEES group (score:
4) 7 and 21days after CEES injury (Supplementary Figure 2).
Also, the clinical evaluation indicated that Dox treatment
yielded similarly lower corneal opacity scores ranging from
1.5 to 2 on the 21st day (Figure 6).
Discussion
Vesicating agent SM causes injuries in ocular tissue at much
lower concentration rather than other organs. Corneal
neovascularization associated with SM is considered a chal-
lenge in terms of both intracellular pathways and clinical
aspects. Despite numerous investigations, effective therapy
to reverse the devastating mechanisms resulting in ocular
injury has not been found [5]. In this study, we investigated
single and combined treatments of NAC and Dox to treat
the rat model of SM-induced cornea with delayed CNV.
To study ocular injury induced in the rat model, CEES was
used in our study as a surrogate substance for SM. CEES is a
mono alkylating agent modifying cellular macromolecules
through an increase of ROS production [24]. Innate antioxi-
dant defense in ocular tissues converting ROS to less reactive
species. SOD acts as a disproportionation of superoxide
Figure 4. Effects of different treatments in H&E staining of corneal tissues after CEES injury. The infiltration of the inflammatory cells was seen in the cornea and
stroma in the CEES group at the 3rd and 7th days. On the delay phase (21st day) dramatic neovascularization appeared in the CEES group (shown by arrow). NAC
and DoxþNAC treatments after 7 days displayed a remodeling stromal and slightly recovered epithelium. The neovascularization score on the 21st day of treat-
ment groups decreased; however, the inflammatory cells infiltrated to stroma still existed.
Figure 5. Effects of different treatments on CNV scores after CEES injury. (A) CNV on the 21st day after CEES cornea injury. (B) Less corneal neovascularization was
observed by the time rats were treated with Dox and DoxþNAC at the 7th day (p-value  .05) and the 21st day (p-value .001) rather than the CEES group. The
CNV in the NACþ CEES group at the 21st day was lower than CEES group (p-value  .01). The mean clinical CNV score indicated that the 21st day post Dox treat-
ment had a significant decrease in the score at about 1.2.
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anion into hydrogen peroxide and molecular oxygen, while
CAT and GPx catalyze the decomposition of hydrogen perox-
ide (H2O2) to water and oxygen. In vitro and in vivo vesicant-
induced oxidative stress in ocular tissues demonstrated the
reduction of catalytic antioxidant activity such as CAT, SOD,
and stored glutathione (GSHþGSSG) [22]. We evaluated the
activity of three antioxidant defense enzymes including CAT,
GPx, and SOD. The low enzyme activity of CAT, GPx, and
SOD was observed after 3 days CEES exposure when the
greatest apoptotic corneal keratinocytes and epithelium deg-
radation were detected using histological assessments. The
CAT and SOD activities were increased by NAC and
DoxþNAC treatment at the 21st day. It could be explained
by the antioxidant capacity of NAC to detoxicate the electro-
philic xenobiotics and modulate the redox signal transduc-
tion [25]. Similar enhancement of antioxidant enzyme activity
was observed in the management of retinal oxidative stress
by NAC [26]. Amir et al. did not announce any changes in
glutathione of aqueous humor 24 h post-2,2-dichlorodiethyl
sulfide (HD) exposure [27]. Our data of enzyme activities did
not show any positive response to Dox treatment in all peri-
ods. Although NAC eye drop could not completely restore
the activity of antioxidant enzymes in general, it promoted
cell survival and cell recovery through ROS elimination.
ROS accumulation to some extent can be a result of the
CEES agents that recruit and activate neutrophils and macro-
phages to induce inflammatory cytokines and signaling path-
ways. We explored the effects of NAC and Dox on tnf-a and
rel-a gene expression, as the main inflammatory pathway.
The expression level of TNF-a increased in the cornea of the
CEES group, which represented the high level of oxidative
stress, rather than healthy rats. Our data showed that NAC
could decrease the TNF-a mRNA expression, probably
through the cellular redox regulation. This alteration was
also illustrated in the reduction of rel-a gene expression fol-
lowing NAC treatment in the long term. TNF-a is one of the
pro-inflammatories elevated in the cornea of BALB/c male
mice with alkali corneal burns. The injection of infliximab, an
anti-TNF-a antibody, was able to reduce inflammatory cyto-
kines such as IL-1b and IL-6 [28]. TNF-a cytokine potentially
recruits neutrophil and macrophage (MQ) cells into the
injured cornea via inducing the Rel-a to form nuclear factor
kappa B (NF-jB) transcription factor [29,30]. Correlation
analysis indicated the suppression effect of NAC on inflam-
matory signals between TNF-a and Rel-a.
The result of histological assessment exhibited a massive
infiltration of inflammatory cells in the cornea exposed to
CEES in the whole period of our experiment. Although NAC
slightly declined the number of infiltrated neutrophils in the
stroma of cornea, the number of macrophages was still high
compared to the healthy cornea. Cxcl-1 is known as the
main chemo-attractive factor for neutrophils in inflamed tis-
sues. It has been reported that murine alkali-burned corneas
associated with dry eye had a high level of Cxcl-1 expression,
and dexamethasone treatment decreased both Cxcl-1 expres-
sion and infiltration on neutrophils [14]. The over-expression
of cxcl-1 gene was detected overall days of groups, and its
down-regulation also occurred in the following days.
Likewise, there was no relationship between Rel-a and Cxcl-1
expression. It was suggested that Cxcl-1 chemokine expres-
sion was not under the effect of Rel-a, as the main transcrip-
tion factor, and other inflammatory signals may affect Cxcl-1
expression. Lu et al. reported that alkali-injured mice with
TNF receptor 1-deficient (TNF-Rp55 KO) suppressed expres-
sion of angiogenesis factors such as VEGF and nitric oxide
synthases (iNOS), but intracorneal infiltration of leukocytes
did not change, probably because it had few effects on the
expression of a sustained CCL-2 expression [31].
Inflammation and downstream signals derived from
immune cells after cornea injury trigger neovascularization
with the involvement of angiogenesis factors and extracellu-
lar matrix (ECM) degradation [30]. In regard to the histo-
logical and clinical evaluations, DoxþNAC had significant
effects on CNV inhibition on the 21-day CEES-induced injury
group. The combined treatment DoxþNAC at the 21st day
resulted in the lowest CNV and opacity score. In terms of
angiogenesis factor expression, VEGF-A mRNA expression
declined in the treatment group, especially in the
DoxþNACþCEES group. The reduction of VEGF-A expres-
sion in the NACþCEES group was correlated with the low
expression of Rel-a. Activated NF-jB transcription factor has
been shown to contribute to the production of VEGF-A that
plays the main role in endothelial cell proliferation and CNV
[32]. Solely doxycycline eye drop has also been proved to
decrease CNV in various mechanisms. Wenru Su et al. in
2013 showed that doxycycline can inhibit human umbilical
vein endothelial cells (HUVEC) proliferation by attenuating
phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt)
pathway [33]. A study reported that doxycycline can function
as an inhibitor on tyrosine-phosphorylated VEGF-R1 and
VEGF-R2. In addition, doxycycline by reducing the activity of
matrix metalloproteinases (MMP2,9) activity and their expres-
sion can stop VEGF-A chamber release [34]. In our study,
NAC and doxycycline declined both MMP-2 and -9 mRNA
expression at the 21st day after treatment. It has been
proved that doxycycline can control mmp-2, 9 gene expres-
sion by attenuating the PI3K/Akt pathway [33]. MMP2, 9
belong to the family of zinc-dependent endopeptidases that
are activated by TNF-a in neutrophil and macrophages [6].
MMP2, 9 have the ability to break down the tight junction as
well as collagen IV in the basement membranes of
Figure 6. Effects of different treatments on cornea opacity scores after CEES
injury. On the 21st day, the corneal opacity score was lower in both
Doxþ CEES and DoxþNACþ CEES groups, at about 2.5 and 2 respectively.
Indicators p-value  .05: , p-value  .01: , p-value  .001: compared
with the CEES group at the 1st, 3rd, 7th, and 21st days separately. Nac: N-acetyl
cysteine; Doxy: doxycycline.
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endothelial [35]. In the alkali injury of the cornea, MMP-9 is
responsible for the degradation of the basement membrane
and tight junction between epithelial cells [16]. Our H&E
staining showed that the existence of interrupted squamous
epithelium was significant in the cornea injured with CEES;
however, it was improved in the long run treatment. The
process of healing of the injured cornea is complex, espe-
cially when ECM is remodeled, or the migration of inflamma-
tory and endothelium cells is not controlled, thus, further
studies are needed to remove the veil of ignorance.
However, the limitation of our study was to analyze inflam-
matory and angiogenesis factors just at the level of mRNA
expression. It is suggested that the protein expression of
TNF-a, Rel-a, Cxcl-1, VEGF-A, and also, the enzyme activity of
MMP-2,9 will be measured to shed a light on the effects of
NAC and doxycycline on the model of SM-injured cornea.
Conclusion
The results indicated that the consequence of progressive
inflammation in the CEES-injured cornea of rats led to the
induction of neoangiogenesis. We found the beneficial
effects of NAC and Dox treatment in decreasing developed
CNV and angiogenesis factors. Despite the decline of inflam-
matory signals, these treatments could not completely pre-
vent the infiltration of inflammatory cells. More research
needs to have better insight into the recruitment pattern of
macrophages.
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